BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8605667)

  • 1. Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study.
    Contois JH; McNamara JR; Lammi-Keefe CJ; Wilson PW; Massov T; Schaefer EJ
    Clin Chem; 1996 Apr; 42(4):515-23. PubMed ID: 8605667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study.
    Contois J; McNamara JR; Lammi-Keefe C; Wilson PW; Massov T; Schaefer EJ
    Clin Chem; 1996 Apr; 42(4):507-14. PubMed ID: 8605666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of apolipoprotein A-I, apolipoprotein B, and lipoprotein(a) in a population sample.
    Leino A; Impivaara O; Kaitsaari M; Järvisalo J
    Clin Chem; 1995 Nov; 41(11):1633-6. PubMed ID: 7586554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma apolipoproteins AI and B: reference values in the Isère population and determination of individual values].
    Foulon T; Laporte F; Payen N; Groslambert P
    Ann Biol Clin (Paris); 1998; 56(4):451-6. PubMed ID: 9754281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of plasma small-dense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B.
    Menys VC; Liu Y; Mackness MI; Caslake MJ; Kwok S; Durrington PN
    Clin Chim Acta; 2003 Aug; 334(1-2):95-106. PubMed ID: 12867279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.
    Schaefer EJ; Lamon-Fava S; Cohn SD; Schaefer MM; Ordovas JM; Castelli WP; Wilson PW
    J Lipid Res; 1994 May; 35(5):779-92. PubMed ID: 8071601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoturbidimetric method for routine determinations of apolipoproteins A-I and B.
    Brustolin D; Maierna M; Aguzzi F; Zoppi F; Tarenghi G; Berti G
    Clin Chem; 1991 May; 37(5):742-7. PubMed ID: 1903334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group.
    Connelly PW; Poapst M; Davignon J; Lussier-Cacan S; Reeder B; Lessard R; Hegele RA; Csima A
    Can J Cardiol; 1999 Apr; 15(4):409-18. PubMed ID: 10322250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
    St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
    Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference values for apolipoproteins A-I and B in healthy subjects, by age.
    Zunić G; Jelić-Ivanović Z; Spasić S; Stojiljković A; Majkić-Singh N
    Clin Chem; 1992 Apr; 38(4):566-9. PubMed ID: 1568324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
    Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lipoprotein(a) distribution in the Framingham Offspring Study as determined with a commercially available immunoturbidimetric assay.
    Contois JH; Lammi-Keefe CJ; Vogel S; McNamara JR; Wilson PW; Massov T; Schaefer EJ
    Clin Chim Acta; 1996 Sep; 253(1-2):21-35. PubMed ID: 8879836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol].
    Hayashi T; Hirano T; Shiobara T; Suguro T; Adachi M
    Rinsho Byori; 2006 Jun; 54(6):569-75. PubMed ID: 16872005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological reference ranges for low-density lipoprotein cholesterol and apolipoprotein B for identification of increased risk of ischaemic heart disease.
    Vermaak WJ; Kotze JP; van der Merwe AM; Becker PJ; Ubbink JB; Barnard HC; Roux FG; Schoeman JJ; Strydom GL
    S Afr Med J; 1991 Apr; 79(7):367-71. PubMed ID: 2014459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New assay of apolipoproteins A-I and B by rate nephelometry evaluated.
    Maciejko JJ; Levinson SS; Markyvech L; Smith MP; Blevins RD
    Clin Chem; 1987 Nov; 33(11):2065-9. PubMed ID: 3119254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?
    Manfroi WC; Zago AJ; Campos M; Alves A; Brisolara ML; de Souza J; Candiago RH; Kirschnick L; Ribeiro L; Ordovás K; Leitão C; Cruz R
    Arq Bras Cardiol; 1999 Jun; 72(6):657-68. PubMed ID: 10752172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of children and coronary heart disease patients with low high density lipoprotein cholesterol levels.
    Ohta T; Saku K; Nakamura R; Maung KK; Matsuda I
    Atherosclerosis; 1998 Apr; 137(2):321-8. PubMed ID: 9622275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years.
    Simons LA; Simons J; Friedlander Y; McCallum J
    Atherosclerosis; 2001 Nov; 159(1):201-8. PubMed ID: 11689222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.
    Swinkels DW; Demacker PN; Hendriks JC; Brenninkmeijer BJ; Stuyt PM
    Atherosclerosis; 1989 May; 77(1):59-67. PubMed ID: 2719763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.